financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Nutanix, Inc.
Mar 4, 2024 11:01 PM

01:00 PM EST, 02/29/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our target to $71 from $47 on a P/S of 7.5x, above its three-year average on good sales execution and a favorable deal pipeline, using our next-12-month sales estimate of $2.3B. We lift our FY 24 EPS view to $1.07 from $0.95 and FY 25's to $1.33 from $1.21. NTNX posted Q2 sales of $565.2M, above consensus by $14.8M, while non-GAAP EPS of $0.46 beat by $0.17. Revenue rose 16.2% Y/Y from solid Subscription revenue growth (+18% Y/Y) as ACV billings outperformed, up 23% Y/Y, from higher-than-anticipated renewals. We note NTNX's commentary around a continued uncertain macro environment, and longer average sales cycles, which likely impacted contract duration of 2.8 years in Q2, lower than Q1. However, these results reflect the firm's strong execution in securing and keeping pace with renewals and expansion deals, as well as maintaining healthy pricing levels in spite of these challenges. Its upbeat guidance and a higher mix of large deals in the pipeline further support our positive view of the business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of O'reilly Automotive Inc.
Jul 8, 2025
12:30 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We are updating our price target for the company's recently-completed 15-for-1 stock split. As a result, our price target goes to $100 from $1,500, based on a 2026 P/E of...
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Research Alert: CFRA Retains Buy Opinion On Shares Of Alnylam Pharmaceuticals, Inc.
Jul 8, 2025
01:00 PM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to $367 from $343 based on our net present value (NPV) analysis. We lift our 2025 EPS estimate to $1.15 from $0.69, as we...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Amphenol Corporation
Jul 8, 2025
11:30 AM EDT, 07/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price to $110 from $85, shifting to a P/E of 37x our 2026 EPS view, above APH's three-year average (~28x) on sizeable AI tailwinds. We also...
8 reasons to tap your home for cash: Expenses you can use home equity for
8 reasons to tap your home for cash: Expenses you can use home equity for
Jul 8, 2025
Key takeaways Home equity loans and HELOCs offer more money at a lower interest rate than credit cards or personal loans. Some of the most common (and best) reasons for using home equity include paying for home renovations, consolidating debt and covering emergency or unexpected costs. Although allowable, it's best to avoid using home equity for discretionary purchases and expenses....
Copyright 2023-2025 - www.financetom.com All Rights Reserved